GlassScriptPhysician profile
Robert J Desnick
NPI 1861460859
$206,553.95
in general payments reported to CMS, 2019-2025
9 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Clinical Genetics (M.D.) provider received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $56K · 2021: $17K · 2022: $18K · 2023: $57K · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $21K · Consulting Fee: $2,250 · Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,375.00 |
| Travel and Lodging | $20,873.34 |
| Consulting Fee | $2,250.00 |
| Food and Beverage | $293.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $121,310.02 | 2019-2023 | |
| Mitsubishi Tanabe Pharma Development America, INC. | $50,468.85 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $11,274.73 | 2019-2022 | |
| Genzyme Corporation | $8,208.28 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $7,245.10 | 2019-2022 | |
| Tanabe Pharma America, INC. | $6,153.40 | 2022-2023 | |
| Sanofi US Services INC. | $1,500.00 | 2022 | |
| Eusa Pharma (US) LLC | $343.39 | 2022 | |
| Alexion Pharmaceuticals, INC. | $50.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Desnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.